Plain-English translation of NCT07264036 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Head and neck cancer survivors sometimes develop problems with speech and swallowing after surgery or radiation therapy, because the soft palate and throat muscles don't close properly during these activities. This study uses detailed tests to understand how common and severe these problems are, and then evaluates whether a pharyngeal wall augmentation injection — a simple injectable treatment — can help improve speech clarity and swallowing safety in patients who need it.
Many cancer survivors struggle with nasal-sounding speech, food going into the nose during swallowing, and reduced quality of life, but doctors don't have enough information about the best ways to diagnose or treat these problems. This research aims to fill that gap and help improve care for this overlooked group of patients.
You likely qualify if…
You likely don't qualify if…
You will attend visits for comprehensive evaluations that include a physical exam of your mouth and throat, a flexible camera scope to watch your palate move during speech and swallowing, speech recordings and analysis, and swallowing tests. If testing confirms you have velopharyngeal dysfunction and you choose to receive the injectable treatment as part of standard care, you'll have follow-up assessments to see if it helps. The entire study involves detailed measurements of your speech and swallowing function before and potentially after treatment.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States